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Summary
 
Negative selection is the process by which the developing lymphocyte receptor repertoire rids
itself of autoreactive specificities. One mechanism of negative selection in developing T cells is
the induction of apoptosis in immature CD4
 
1
 
CD8
 
1
 
 (DP) thymocytes, referred to as clonal de-
letion. Clonal deletion is necessarily T cell receptor (TCR) specific, but TCR signals alone are
not lethal to purified DP thymocytes. Here, we identify two distinct mechanisms by which
TCR-specific death of DP thymocytes can be induced. One mechanism requires simultaneous
TCR and costimulatory signals initiated by CD28. The other mechanism is initiated by TCR
signals in the absence of simultaneous costimulatory signals and is mediated by subsequent in-
teraction with antigen-presenting cells. We propose that these mechanisms represent two dis-
tinct clonal deletion strategies that are differentially implemented during development depend-
ing on whether immature thymocytes encounter antigen in the thymic cortex or thymic
medulla.
 
A
 
central feature of the immune system is its ability to
respond to foreign antigens while tolerating self-anti-
gens. Burnet’s model of self-nonself discrimination pro-
posed that receptor engagements that were stimulatory for
mature immune cells would induce immature immune cells
to die, resulting in the removal of autoreactive receptor spec-
ificities from the developing repertoire (1–2). The removal
of autoreactivities from the functional lymphocyte reper-
toire is known as negative selection. For T cells, negative
selection can occur at different developmental stages in the
thymus by a variety of mechanisms, including (
 
a
 
) clonal de-
letion, (
 
b
 
) developmental or clonal arrest, or (
 
c
 
) clonal inac-
tivation or anergy (3–4). CD4
 
1
 
CD8
 
1
 
 double positive
(DP)
 
1
 
 thymocytes in particular are susceptible to clonal de-
letion induced in response to TCR signals (5–7). Curi-
ously, while clonal deletion of DP thymocytes must involve
TCR engagement, TCR engagement by itself is insuffi-
cient to stimulate DP thymocyte apoptosis in vitro (8–12).
Rather, DP thymocyte death has been found to require sig-
nals in addition to TCR, such as those provided by CD28
(9–11). This requirement for second signals parallels the re-
quirement for second signals in TCR-mediated activation
and proliferation of mature single positive (SP) T cells (13).
Because CD28 is not a unique costimulatory molecule for
mature T cells (14–22), it is likely that CD28 is not the only
molecule capable of transducing second signals for TCR
dependent DP thymocyte apoptosis (6, 14, 23–24). Indeed,
other molecules have been implicated in clonal deletion of
DP thymocytes, such as CD30 (21) and fas (25). The role of
fas in negative selection is particularly controversial (26–29).
TCR-dependent apoptosis of mature T lymphocytes
was not foreseen in Burnet’s model of self-nonself discrim-
ination but is now a recognized consequence of mature T
cell activation (reviewed by 30–31). In mature T cells, TCR
signals do not directly induce an apoptotic program, but
rather act indirectly by upregulating surface expression of
members of the TNF family, specifically fas ligand (fasL) and
TNF (32–34). These proteins bind to fas or TNF receptor
(TNFR) which mediate apoptosis through death domains
expressed in their cytosolic regions (35). This mechanism
of apoptosis necessarily results in death of both TCR-stim-
ulated T cells and neighboring (or bystander) cells express-
ing fas or TNFR. In contrast, clonal deletion in the thymus
is presumed not to involve bystander death since it should
be limited to cells directly stimulated by TCR interactions.
In this study we have focused on identifying mechanisms
of TCR-dependent clonal deletion of rigorously purified
DP thymocytes to avoid confounding signals that can result
 
1
 
Abbreviations used in this paper:
 
 CMJ, cortico medullary junction; DP,
double positive; EtBr, ethidium bromide; fasL, fas ligand; FcR, Fc recep-
tor; SP, single positive; TNFR, TNF receptor.
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from contact with other thymic elements. We identify two
distinct mechanisms for generating second signals leading to
TCR-induced DP thymocyte apoptosis: (
 
a
 
) a CD28-depen-
dent mechanism that requires simultaneous engagement of
TCR and CD28 surface molecules, and (
 
b
 
) a CD28-indepen-
dent mechanism initiated by TCR signals but mediated
subsequently by APC signals. While we found that fas sig-
nals can induce DP thymocyte death, they were not in-
volved in either TCR-specific apoptotic mechanism. We
propose that the two mechanisms of DP apoptosis revealed
in this report represent two distinct TCR-specific clonal
deletion strategies in the thymus: (
 
a
 
) a CD28-dependent
mechanism specific for antigens on B7
 
1
 
 cells, i.e., APC and
medullary epithelium, and (
 
b
 
) a CD28-independent mech-
anism specific for antigens on B7
 
2
 
 cells in the thymic cortex.
 
Materials and Methods
 
Mice.
 
Young adult female C57BL/6 (B6) mice, gld/gld mice
(B6-SMN C3H fasL), and lpr/lpr mice (B6 mrl lpr/lpr) were ob-
tained from The Jackson Laboratory (Bar Harbor, ME) and
young adult female B6 Ly5.2 mice were obtained from the Fred-
erick Cancer Research Center (Frederick, MD). CD28-deficient
mice (CD28 KO) (14) were bred to the C57BL/6 background
and maintained at the Bethesda Naval Medical Research Institute.
Mice transgenic for the human 
 
bcl-2
 
 gene (driven by the 
 
lck
 
 prox-
imal promoter [36] were generously provided by Dr. Stanley
Korsmeyer and bred in our facility at the NIH. Mice deficient in
either the p55 TNFR (p55) (37) or both p55 and p75 TNFR (38
and 38a) were obtained from Immunex (Seattle, WA).
 
Cell Preparation.
 
CD4
 
1
 
CD8
 
1
 
 thymocytes were purified from
4–6-wk-old female mice either by panning on anti-CD8 (83-12-5)
coated plates (39) or by Percoll density fractionation (40). Similar
experimental results were obtained with cells isolated by either pro-
cedure. In each case 
 
.
 
95% of isolated cells were CD4
 
1
 
CD8
 
1
 
.
APC were prepared by treating splenocytes with anti-CD4 (RL-
172), anti-CD8 (3-155), anti-Thy-1 (30H12), and rabbit comple-
ment as previously described (3). Viable cells were isolated by
centrifugation over Lymphocyte-M (Cedarlane Laboratory, Ltd.,
Ontario, CA). These cell preparations were free of T cells as de-
termined by CD3 staining and FACS
 
Ò
 
 analysis. Lymph node T
cells were prepared from B6 and gld/gld mice by treating single-
cell suspensions of cells isolated from a pool of popliteal, inguinal,
axillary, brachial, and submandibular lymph nodes with a combi-
nation of anti-class II (M5114), anti-NK1.1 (PK136), anti-HSA
(J11d) culture supernatants, and rabbit complement.
 
Antibodies.
 
Anti-CD28 (37.51 [41]) and anti–TCR-
 
b
 
 (H57-597
[42]) were affinity purified in our laboratory from hybridoma cul-
ture supernatant on columns of protein G– and protein A–Sepharose
(Pharmacia LKB Nuclear, Gaithersburg, MD), respectively. Anti-
CD2 (RM2-5), anti-CD43 (S7), anti-CD27 (LG.3A10), anti-41BB
(1AH2), neutralizing anti–TNF-
 
a
 
 (G281-2626), anti-CD80 (1G10),
anti-FcR (2.4G2), anti-fas (Jo2), and FITC-conjugated anti-HSA,
FITC anti-Ly5.2 (CD45.1) and FITC anti-Ly5.1 (CD45.2) were
purchased from Pharmingen laboratories. FITC-conjugated anti-
CD5 (Ly-1) was purchased from Beckton Dickinson (San Jose, CA).
Anti-CD81 was the product of hybridoma 2F7 (43). Anti-CD9
(9D3 [20]), anti-CD24 (20C9 [44]), anti-CD30 (mCD30.1 [45]),
anti-CD30L (M15 [46]), and anti-B7-2 (GL1 [47]), were gener-
ously provided by Drs. Hiromi Fujiwara (Osaka University, Osaka,
Japan), Charles Janeway (VCI, NIH, Bethesda, MD), Eckhardt
Podack (University of Miami School of Medicine, FL), Phil Mor-
rissey (Immunex, Seattle, WA), and Richard Hodes (NIH, Be-
thesda, MD), respectively.
 
Reagents.
 
Murine recombinant TNF-
 
a
 
 (R&D Labs., Minne-
apolis, MN) was used at a final concentration of 100 ng/ml.
CD30-Ig was generously provided by Dr. Eckhardt Podack. Cy-
closporine A was purchased from Calbiochem-Novabiochem (La
Jolla, CA) and cycloheximide, wortmannin, and GF109203X were
purchased from Sigma Chem. Co. (St. Louis, MO). The caspase
inhibitor Cbz-Val-Ala-Asp-(Ome)-fluoromethyl ketone (ZVAD-
FMK) was purchased from Enzyme Systems Products (Dublin, CA).
 
Culture and Stimulation Conditions.
 
Purified cell populations
were cultured for 16–20 h in a 7% CO
 
2
 
 humidified incubator in
RPMI 1640 supplemented with 5 
 
3
 
 10
 
2
 
5
 
 M 2-ME and 10% FCS
at 37
 
8
 
C. Single-cell suspensions of DP thymocytes were plated in
24-well tissue culture plates (Corning Glass, Corning, NY) at a
cell density of 2 
 
3
 
 10
 
6
 
/ml in a total of 500 
 
m
 
l per well. When
mixed culture experiments were performed, DP cells from CD28-
deficient mice were incubated with DP cells from Ly5.2 mice at a
1:1 ratio and with LN T from Ly5.2 mice at a 1:2 or 1:3 ratio.
APC were mixed with DP thymocytes at a 2:1 or 3:1 ratio and
3 
 
3
 
 10
 
6
 
 total cells were plated per well. For stimulation, wells in
a 24-well plate were coated with antibody combinations by incu-
bating them overnight at 4
 
8
 
C with 350 
 
m
 
l of a 10 
 
m
 
g/ml (most
antibodies) or 50 
 
m
 
g/ml (anti-CD28) of each affinity-purified an-
tibody specified in PBS.
 
Staining and Flow Cytometry.
 
Cell death was assayed as previ-
ously described (9, 48). In brief, 5 
 
3
 
 10
 
5
 
 cultured cells were incu-
bated with saturating concentrations of the FITC conjugated an-
tibodies specified in staining medium (HBSS, 0.5% BSA, 0.5%
NaN
 
3
 
) for 30 min at 4
 
8
 
C, washed, and then incubated with a 1
 
m
 
g/ml ethidium bromide (EtBr; Sigma) for another 30 minutes at
4
 
8
 
C. Cells were washed again and analyzed using CellQuest soft-
ware on a FACScan
 
Ò
 
. In mixed cell culture experiments, DP thy-
mocytes were identified by expression of Ly5.1, Ly5.2, HSA, and
Thy-1, as indicated.
 
Measures of Cell Death.
 
Specific cell death (% cell death) was
determined by EtBr staining and was calculated as a normalized
value as follows: (%EtBr
 
1
 
 (stimulated) 
 
2
 
 %EtBr
 
1
 
 (unstimulated
control))/(100 
 
2
 
 %EtBr
 
1
 
 control). Background EtBr staining of
cultured DP thymocytes ranged between 18 and 30%. To com-
pare thymocyte apoptosis in response to TCR-CD28 signals among
experimental groups with different internal controls (i.e., differ-
ent mouse strains, different solvents, etc.), individual responses
were normalized and expressed as a killing index. The killing in-
dex was calculated as follows: (% DP cell death induced by TCR-
CD28 under experimental conditions)/(% DP cell death induced
by TCR-CD28 under control conditions). Killing index 
 
5
 
 1.0
means that the indicated condition did not affect TCR-CD28–
induced apoptosis; killing index 
 
.
 
1 means that the indicated
condition inhibited TCR-CD28–mediated death. All experi-
ments displayed were performed three or more times with similar
results.
 
Results
 
Surface Molecules Expressed by CD4
 
1
 
CD8
 
1
 
 Thymocytes
That Kill Cells by Either TCR-dependent or TCR-independent
Mechanisms.
 
To identify the molecular requirements for
TCR-dependent DP thymocyte apoptosis, we stimulated
purified DP thymocytes in vitro and assessed them for EtBr
uptake, which identifies cells undergoing apoptosis (9, 48).
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We initially examined surface molecules for their ability to
induce apoptosis of DP thymocytes in the absence of TCR
engagement (Fig. 1 
 
a
 
). In fact, we identified two stimuli
that induced DP thymocyte apoptosis in a TCR-
independent manner, namely (
 
a
 
) fas engagement by immo-
bilized platebound antibody and (
 
b
 
) TNF
 
a
 
 engagement of
TNFR. Antibody engagement of surface fas molecules in-
duced apoptosis of most DP thymocytes, consistent with
others’ observations and the high expression of fas on DP
thymocytes (49); and soluble TNF-
 
a
 
 engagement of sur-
face receptors induced apoptosis of 20% of DP thymocytes,
which may represent a distinct TNF-
 
a
 
 responsive subpop-
ulation (50) (Fig. 1 
 
a
 
). Our present finding that immobi-
lized anti-fas antibody efficiently induces DP thymocyte death
differs from that of Ogasawara et al. (51) who found that
metabolic inhibitors were necessary to enhance DP thymo-
cyte death induced by soluble anti-fas antibodies. We think
that our different observations may be due to differences in
the efficiency by which fas is crosslinked by soluble versus
immobilized antibody.
Even though fas and TNFR are members of the TNFR
family of proteins (52), many of which induce cell death,
platebound antibody engagement of three other members
of the family (CD27, CD30, and 41BB) did not affect DP
thymocyte viability (Fig. 1 
 
a
 
, 
 
right
 
). In fact, no other mole-
cules examined, including platebound antibodies specific for
CD4, CD5, CD8, CD69, and LFA-1 (9 and data not shown),
were capable of mediating TCR-independent DP thy-
mocyte apoptosis (Fig. 1 
 
a
 
).
We next assessed molecules that could induce DP thy-
mocyte apoptosis in the presence of TCR engagement (Fig.
1 
 
b
 
). As expected (9), TCR engagement alone failed to in-
duce significant DP thymocyte apoptosis (Fig. 1 
 
b
 
). We ex-
amined three specific sets of surface proteins for their ability
to cooperate with the TCR to kill DP thymocytes (Fig. 1 
 
b
 
and data not shown), namely (
 
a
 
) molecules thought to be
costimulatory (CD9 [20]), CD28 [reviewed in 53], CD43
[19], and CD81 [54], (
 
b
 
) coactivating molecules that en-
hance TCR signaling (CD2, CD4, CD5, CD8, CD24,
CD69, and LFA-1), and (
 
c
 
) selected TNFR family mem-
bers (CD27, CD30, 41BB), which may also exhibit co-
stimulatory activity (15, 17–18, 21–22, 52). Importantly,
antibody engagement of each of these molecules cooper-
ated with TCR signaling to upregulate CD5 expression on
DP thymocytes (data not shown). However, only CD28
cooperated with TCR to induce DP thymocyte apoptosis
(Fig. 1 
 
b
 
).
Thus, there exist both TCR-independent and TCR-
dependent mechanisms of DP thymocyte apoptosis: TCR-
independent mechanisms can be mediated by either fas or
TNFR engagement, whereas the TCR-dependent mecha-
nisms can be mediated by coengagement of TCR and CD28.
 
TCR/CD28–induced Apoptosis Is Independent of fas and
TNFR Interactions, and Is Strictly Confined to DP Thymocytes
That Have Received both TCR and CD28 Signals.
 
The abil-
ity of fas and TNF-
 
a
 
 to mediate DP thymocyte apoptosis
raised the possibility that both mechanisms of DP thy-
mocyte apoptosis (TCR-independent and TCR-dependent)
may ultimately result from engagement of fas or TNFR.
To address this possibility, we examined the ability of TCR-
CD28 coengagement to kill purified DP thymocytes from
mice deficient in (
 
a
 
) fas (lpr, reviewed in reference 55), (
 
b
 
)
fas ligand (gld), (
 
c
 
) the p55 murine TNFR, or (
 
d
 
) both the
p55 and p75 murine TNFRs (38, 38a) (Fig. 2). None of
Figure 1. TCR-independent
and TCR-dependent mecha-
nisms of DP thymocyte apopto-
sis. Antibodies against cell surface
molecules that possess costimu-
latory/coactivating activity and
antibodies against TNFR family
members were assessed for their
ability to induce apoptosis of rig-
orously purified DP thymocytes.
Control EtBr percentages ranged
between 18 and 30% in all exper-
iments presented in this report.
(a) Only TNF-a and fas induce
death of DP thymocytes in the
absence of TCR stimulation. DP
thymocytes isolated from young
adult female B6 mice were stim-
ulated by platebound antibodies or
by 100 ng/ml recombinant mu-
rine TNF-a. Cells were harvested
after overnight incubation and
percent cell death was quantitated
by EtBr staining (see Materials
and Methods). (b) Only CD28 cooperates with TCR to induce death of DP thymocytes. Cells were stimulated by platebound antibody combinations as
indicated. Anti–TCR-b (H5-597) was plated at a concentration of 10 mg/ml. Even though anti-CD28 antibody was unique in its ability to induce cell
death, every experimental antibody enhanced TCR-mediated upregulation of CD5 (data not shown). In a and b, each experimental antibody (other than
anti-CD28) was plated at both 10 and 50 mg/ml concentrations. Results from the 10 mg/ml plating preparations are shown and were indistinguishable
from results with 50 mg/ml concentrations. Cells were harvested and percent cell death was quantitated by EtBr staining (Materials and Methods).
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the mutations significantly affected the ability of TCR-
CD28 coengagement to induce apoptosis of DP thy-
mocytes, indicating that neither fas nor the TNF receptors
p55 or p75 were required (Fig. 2). In addition, neutralizing
anti–TNF-a antibodies had no effect on TCR-CD28–
induced apoptosis of wild-type DP thymocytes (data not
shown). We also found that TCR-CD28–induced death
was not blocked by CD30 Ig, a fusion protein that blocks
CD30-CD30L interactions (data not shown). We conclude
that TCR-CD28 coengagement induces DP thymocyte
apoptosis by a mechanism that is independent of fas/fasL,
TNF-TNFR, and CD30-CD30L interactions.
While fas and TNFR are not involved in TCR-CD28–
induced apoptosis, additional members of the TNFR family
expressing the “death domain” associated with apoptotic
signaling continue to be identified (56–58). To determine
if TCR-CD28 coengagement induced apoptosis in trans of
bystander thymocytes via ligands (known and unknown),
we used thymocytes from CD28 KO mice as bystander
cells for they do not die in response to TCR-CD28 stimu-
lation (Fig. 3 a). In this mixed culture experiment, we
stimulated cocultures of DP thymocytes from wild-type
(B6-Ly5.2) and CD28 KO mice with both anti-TCR and
anti-CD28 platebound antibodies (Fig. 3 b). We found that
the majority of wild-type DP thymocytes died in cocul-
tures in response to TCR-CD28 coengagement. In con-
trast, bystander CD28 KO DP thymocytes did not die even
though they were present in the same cocultures and even
though they were stimulated by the immobilized anti-TCR
antibodies (Fig. 3 c). These results demonstrate that TCR-
CD28 coengagement only induces death of DP thymocytes
that had been stimulated by both TCR and CD28 signals,
and suggests one of two scenarios as illustrated in Fig. 3 d.
Either TCR-CD28 transduces intracellular signals that di-
rectly activate an intrinsic death program in DP thymo-
cytes, or TCR-CD28 coengagement stimulates surface ex-
pression of an unknown death domain bearing molecule
that signals cell death upon interaction with its ligand which
must also be expressed on DP thymocytes. In the latter
case, the death receptor-ligand interaction could conceiv-
ably operate either on an individual DP thymocyte (i.e., cis)
or between interacting DP thymocytes (trans).
Identification of Apoptotic Signals Generated by TCR/CD28
Stimulation. To characterize the molecular basis for
TCR-CD28–induced apoptosis of DP thymocytes, we as-
sessed specific inhibitors for their ability to abrograte DP
thymocyte death (Fig. 4). We found that neither cyclospo-
rine A (reviewed in reference 59) nor wortmannin (60, 61)
inhibited TCR-CD28–mediated death (Fig. 4), indicating
that calcineurin and PI 3-kinase activity are not required.
In contrast, DP thymocyte apoptosis induced by TCR-CD28
coengagement was inhibited by (a) GF109203X, a specific
inhibitor of protein kinase Cg (PKCg (61, 62), (b) the pro-
tein synthesis inhibitor, cycloheximide, and (c) the caspase
(ICE-family protease) inhibitor, ZVAD-FMK (63, 64) (Fig.
4). Consistent with the participation of caspases, TCR-CD28
coengagement failed to induce significant apoptosis in DP
thymocytes from bcl-2 transgenic mice which constitu-
tively overexpress the anti-apoptotic bcl-2 protein (Fig. 4).
These data further suggest that the death mechanism ini-
tiated by TCR-CD28 coengagement is distinct from that
initiated by fas engagement, for unlike TCR-CD28–medi-
ated death, fas mediated death of thymocytes is not inhib-
itible by cycloheximide (65, 66) and may not be inhibitable
by bcl-2 (67). To demonstrate this directly, we compared
the effect of bcl-2 on DP thymocyte apoptosis induced by
fas and TCR-CD28 engagement (Fig. 5). In this experi-
ment, we cultured DP thymocytes from wild-type and bcl-2
transgenic mice with three different stimulators of apopto-
sis: dexamethasone, platebound antibodies against fas, and
platebound antibodies against TCR-CD28. As expected,
dexamethasone killed wild-type DP thymocytes but not DP
thymocytes from bcl-2 transgenic mice (Fig. 5). More im-
portantly, DP thymocytes that expressed bcl-2 were sus-
ceptible to fas mediated death but resistant TCR/CD28-
induced death (Fig. 5). Thus, the death program initiated
by TCR-CD28 coengagement is distinct from that initi-
ated by fas engagement.
We conclude that apoptotic signals generated by TCR-
CD28 coengagement are mediated by PKCg, require pro-
tein synthesis, and result in the activation of intracellular
caspases that are regulated by bcl-2.
Figure 2. TCR-CD28 killing of DP thymocytes is not mediated by
fas-fasL or TNF-TNFR interactions. DP thymocytes were isolated from
the mice indicated (wild-type B6, gld/gld (fasL deficient), lpr/lpr (fas de-
ficient), TNFR (p55)–deficient, and TNFR (p55 and p75)–deficient mice
strains. Single-cell suspensions were stimulated overnight by platebound
anti–TCR-b and anti-CD28 antibodies, and then were harvested and
stained with EtBr. To compare thymocyte apoptosis from different mouse
strains with different internal controls, we have normalized individual re-
sponses to their respective controls. The normalized value is referred to as
a killing index.  o
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Identification of a TCR-dependent but CD28-independent
Mechanism of DP Thymocyte Apoptosis. Our studies using
an array of antibodies to known molecules on the surface of
DP thymocytes did not identify any proteins other than
CD28 that could cooperate with TCR to induce DP thy-
mocyte apoptosis. To determine if any such molecule ex-
isted, we asked whether APC expressed ligands, known or
unknown, for surface molecules that would cooperate with
TCR to induce DP thymocyte apoptosis. In this coculture
experiment, we stimulated DP thymocytes from wild-type
and CD28 KO mice with platebound anti-TCR in the
presence of APC. We confined our assessment of EtBr stain-
ing to DP thymocytes by excluding APCs from the analysis
using an allelic marker, Ly5. DP thymocytes from wild-
type mice died in response to TCR stimulation in the pres-
ence of APC. More importantly, DP thymocytes from CD28
KO mice also died in response to TCR stimulation in the
presence of APC, indicating that APC possess ligands that
engage molecules other than CD28 that can induce death
of TCR-stimulated thymocytes. It is important to note that
this CD28-independent mechanism of DP thymocyte death
strictly requires engagement of TCR on DP thymocytes, as
APCs did not kill unstimulated CD28 KO DP thymocytes
(Fig. 6). From these data we can conclude that APC ex-
press or secrete ligands for surface molecules on DP thy-
mocytes that are capable of cooperating with the TCR to
induce TCR-dependent but CD28-independent apoptosis.
CD28-dependent and CD28-independent Mechanisms of TCR
Induced DP Thymocyte Apoptosis Are Distinct. The present
results clearly indicate that CD28 is not the only surface
Figure 3. Only TCR-CD28–stimulated DP thymocytes die in re-
sponse to TCR-CD28 coengagement. (a) TCR-CD28 stimulation will
not kill bystander CD28 KO DP thymocytes. Individual populations of
DP thymocytes from wild-type B6 mice and CD28 KO mice were cul-
tured and stimulated independently with platebound antibodies. % Cell
death of each population of DP thymocytes was quantitated and normal-
ized as described in Materials and Methods. (b) Experimental design. DP
thymocytes from wild-type mice (CD281Ly5.21) were mixed in a 1:1 ratio
with DP thymocytes from CD28-deficient mice (CD282/2Ly 5.11) and
stimulated by platebound anti–TCR-b and anti-CD28. Thymocytes
were harvested after overnight culture and percent cell death in each pop-
ulation was determined. CD281/1 and CD282/2 DP thymocytes were
distinguished by the presence or absence of Ly5.1 staining. (c) Bystander
CD28 KO DP thymocytes are not killed by TCR-CD28 signals. DP thy-
mocytes were isolated from wild-type and CD28-deficient (CD28 KO)
mice which differed in Ly5 expression such that wild-type DP thymo-
cytes were Ly5.21 and CD28 KO thymocytes were Ly5.11. Harvested
cells were stained with both anti-Ly5.1 antibody and EtBr to determine
cell death in each population of cocultured DP thymocytes. Percent cell death was quantitated and normalized as described in Materials and Methods. (d)
Schematic of the mechanism by which TCR-CD28 coengagement kills DP thymocytes. This figure illustrates two possible CD28-dependent mecha-
nisms of TCR-mediated apoptosis of DP thymocytes, both of which result in death exclusively of TCR-CD28–stimulated DP thymocytes. The upper
figure (i) illustrates one scenario in which simultaneous coengagement of TCR and CD28 molecules directly and cell-autonomously induces an apo-
ptotic program. The lower figure (ii) illustrates an alternative scenario in which simultaneous coengagement of TCR and CD28 induces expression of a
death domain containing receptor (Y) that signals apoptosis upon interaction with its ligand (Y-L, Y ligand) that is also expressed on DP thymocytes. In
this latter case, the ligand could conceivably engage the death receptor in either cis or trans.
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molecule that the TCR can use to kill DP thymocytes.
However, it is possible that even though CD28-dependent
and CD28-independent mechanisms of TCR-induced DP
thymocyte apoptosis are mediated by different surface re-
ceptor molecules on DP thymocytes, the second signals in-
duced by these different proteins might be identical. That
this is not the case was revealed by experiments in which
TCR and second signals were induced sequentially rather
than simultaneously. In this experiment, we prestimulated
DP thymocytes with immobilized anti-TCR for 6 h and
subsequently transferred them to cultures with platebound
anti-CD28. We found that death of prestimulated DP thy-
mocytes was not affected by subsequent stimulation through
CD28 (Fig. 7 a). In fact, only subsequent coengagement of
both TCR and CD28 together increased apoptosis of pre-
stimulated DP thymocytes above background (Fig. 7 a). In
contrast, we found in the same experiment that DP thy-
mocytes from CD28 KO mice similarly prestimulated with
immobilized anti-TCR and subsequently transferred to
APCs were killed efficiently (Fig. 7 b). Thus, to stimulate
DP thymocyte apoptosis, TCR and second signals induced
by CD28 must be generated simultaneously, whereas TCR
and second signals induced by APC can be generated se-
quentially, as illustrated in Fig. 7 c. Consequently, CD28-
dependent and CD28-independent pathways of cell death
represent two distinct mechanisms by which TCR can in-
duce DP thymocyte apoptosis.
Characterization of TCR-dependent but CD28-independent
Mechanisms of DP Thymocyte Apoptosis. To determine if fas/
fasL interactions were involved in APC-induced cell death,
we prestimulated CD28 KO DP thymocytes with platebound
Figure 4. Inhibitors of TCR-CD28–mediated death of DP thy-
mocytes. DP thymocytes from wild-type (B6) mice were stimulated by
platebound anti–TCR-b and anti-CD28 in the presence or absence of
the following pharmacological agents: the calcineurin inhibitor, cyclospo-
rine A (1 mg/ml); the PI-3-kinase inhibitor, wortmannin (800 ng/ml); the
PKCg inhibitor, GF109203x (800 ng/ml); the protein synthesis inhibitor,
cycloheximide (10 mg/ml); and the caspase inhibitor, ZVAD-FMK (100
mM). To compare the effects of various reagents on TCR-CD28–medi-
ated DP thymocyte apoptosis in experiments performed with different
solvent controls, individual responses were normalized to their respective
controls (killing index). As positive controls for the pharmacologic agents
used: cyclosporine A and GF109203x used in this experiment inhibited
TCR-mediated CD5 upregulation, and wortmannin used in this experi-
ment blocked NK-mediated target cell lysis (data not shown). Also dis-
played in the same format are the results of anti–TCR-CD28 stimulation
of DP thymocytes isolated from bcl-2 transgenic mice.
Figure 5. Distinct signaling mechanisms of DP thymocyte apoptosis as
revealed by differential sensitivity to bcl-2. DP thymocytes isolated from
wild-type (B6) and bcl-2 transgenic (bcl-2 TG) mice were cultured with
three distinct apoptotic stimuli: dexamethasone (1026 M), platebound anti-
fas antibodies, and platebound anti-TCR and anti-CD28. It can be seen
that transgenic bcl-2 expression abrograted TCR-CD28–mediated apo-
ptosis but not fas-mediated apoptosis of DP thymocytes. It might be
noted that thymocyte death by TCR-CD28 engagement does not in-
volve glucocorticoids as the steroid inhibitor RU486 only blocked death
induced by dexamethasone but not by TCR-CD28 (data not shown).
Figure 6. A CD28-independent mechanism of TCR-mediated death
of DP thymocytes. DP thymocytes from either B6 (Ly 5.11) or CD28
KO (Ly5.11) mice were co-cultured with Ly 5.21 APC in the presence
or absence of platebound anti-TCR. Harvested cells were stained with
both anti-Ly5.1 antibody and EtBr. DP thymocytes were distinguished
from APCs by expression of Ly5.1.
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anti-TCR and then transferred them to cultures containing
APCs isolated from fasL-deficient (gld) mice (Fig. 8). FasL-
deficient APCs from gld mice mediated the death of TCR-
stimulated DP thymocytes as efficiently, if not more efficiently,
than wild-type APCs (Fig. 8). Thus, the CD28-indepen-
dent mechanism of TCR-mediated DP cell death is also
independent of fas/fasL interactions.
It was conceivable that the CD28-independent mecha-
nism of cell death involved a CD28-like molecule such as
CTLA-4 that could be engaged by B7 ligands on APC
(68). In fact, this is not the case, as blocking antibodies to
B7-1 and B7-2 failed to inhibit the ability of APCs to kill
TCR-prestimulated DP thymocytes from CD28 KO mice
(Fig. 8). Similar results were obtained with soluble CTLA-4 Ig
(data not shown). Furthermore, the apoptosis observed was
not a consequence of the transfer of small amounts of anti-
TCR which could bind to Fc receptors (FcR) on APC, for
the anti-FcR antibody 2.4G2 did not inhibit the apoptotic
effects of sequential TCR and APC engagement (Fig. 8).
Finally, these data suggest that TCR prestimulation (in
the absence of CD28 coengagement) “prepares” DP thy-
mocytes to undergo apoptosis upon subsequent interaction
with APC, possibly by inducing expression of surface mol-
ecules containing death domains that bind APC-derived
ligands. Consistent with such a possibility, cycloheximide
reduced by over 70% the number of TCR prestimulated
DP thymocytes that died upon subsequent exposure to
APC (data not shown), indicating that new protein synthe-
sis is required to make TCR prestimulated DP thymocytes
vulnerable to death. TNFR family members are attractive
candidate molecules whose synthesis could be induced on
DP thymocytes by TCR prestimulation. Indeed, CD30 has
been reported to play a role in thymocyte negative selec-
tion (21). Nevertheless, CD30 does not appear to be in-
volved as neither soluble CD30-Ig fusion protein (45) (Fig. 8)
nor antibodies specific for the CD30 ligand (data not shown)
blocked the ability of APCs to mediate CD28-independent
apoptosis of prestimulated DP thymocytes.
Discussion
The present report identifies two distinct mechanisms by
which DP thymocytes can be induced to undergo apopto-
sis in response to TCR signals. In the CD28-dependent
mechanism, TCR signals are delivered simultaneously with
CD28 costimulatory signals, resulting in DP thymocyte death.
In the CD28-independent mechanism, TCR signals are
not accompanied by costimulatory signals and death signals
are generated upon subsequent interaction with APCs. In
addition the present study demonstrates that purified DP
thymocytes can also be induced to undergo apoptosis in the
absence of TCR signals by fas-fasL and TNF-TNFR inter-
Figure 7. CD28-dependent and CD28-independent mechanisms of DP thymocyte apoptosis are distinct. (a) TCR and CD28 signals must be received
simultaneously to mediate death of DP thymocytes. DP thymocytes from B6 mice were prestimulated by platebound anti-TCR-b for 6 h. They were
then removed from this stimulus and transferred to wells that had been precoated with the antibodies indicated on the x-axis. Cells were harvested and
stained with EtBr. The background cell death observed in TCR pretreated groups is likely due to cell damage inflicted by their physical removal from
platebound anti-TCR antibody. (b) TCR and second signals derived from APCs do not have to be simultaneous to induce CD28-independent DP thy-
mocyte death. DP thymocytes from CD28 KO (Ly 5.11) mice were prestimulated by platebound anti–TCR-b for 6 h. They were then removed from this
stimulus and transferred either into wells that had been precoated with anti-CD28 or into wells containing APCs from B6 Ly5.2 mice (in a 2:1 ratio with
the DP cells). Cells were harvested and stained with both Ly5.1 and EtBr. DP thymocytes were distinguished from APC by expression of Ly5.1. As can
be seen, preengagement of TCR on DP thymocytes made them susceptible to APC-induced cell death. (c) Schematic of the CD28-independent mecha-
nism of DP thymocyte apoptosis. This figure illustrates the proposed mechanism by which TCR and subsequent APC signals induce apoptosis of DP thy-
mocytes in a CD28-independent manner. TCR prestimulation of DP thymocytes (1) induces upregulation of a molecule X which might express death
domains (2). Subsequent engagement of molecule X with a ligand expressed by APCs (X ligand or X-L) induces apoptosis of only prestimulated DP thy-
mocytes (3).
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actions, but such TCR-independent mechanisms of apo-
ptosis cannot be the basis for TCR-specific clonal deletion
of DP thymocytes in vivo.
The CD28-dependent mechanism of apoptosis is a con-
sequence of simultaneous TCR and CD28 coengagement
on DP thymocytes and results exclusively in death of DP
thymocytes that have simulataneously received both TCR
and CD28 signals. Such apoptotic signals do not require
the activity of PI 3-kinase, a signaling molecule associated
with CD28 (69), but are resistant to the effects of cyclospo-
rine A, a hallmark of CD28 involvement in mature T cells
(70). Apoptosis induced by TCR-CD28 coengagement re-
quires PKCg and employs a common effector pathway in-
volving caspases that is inhibitible by bcl-2. The present
results are consistent with either of two possibilities: simul-
taneous TCR-CD28 signals induce DP thymocyte death
either by directly initiating a novel intracellular apoptotic
program or by inducing surface expression of an uncharac-
terized death receptor (e.g., a TNFR family member) that
is engaged by surface ligands. In either case, the CD28-
dependent mechanism of death requires that both TCR
and CD28 signals be delivered simultaneously and requires
that the death ligand, if it exists, be expressed on DP thymo-
cytes for these were the only cells present in our cultures.
We favor the possibility that TCR-CD28 directly signals
an apoptotic program because we have found that TCR-
CD28–induced apoptosis of DP thymocytes occurs effi-
ciently at very low cell densities at which cell-cell interac-
tions are unlikely to occur (data not shown). However, we
cannot exclude the possibility that TCR/CD28 stimulation
results in lethal death receptor/ligand interactions occurring
in cis on the surface of individual DP thymocytes (Fig. 3 d).
The mechanism responsible for CD28-independent DP
apoptosis is distinct from that of TCR-CD28–induced ap-
optosis. CD28-independent DP thymocyte apoptosis does
not require costimulatory signals. Rather, TCR engage-
ment alone on DP thymocytes appears sufficient to induce
surface expression of a molecule which triggers death upon
subsequent engagement by ligands expressed by APCs.
This proposed surface molecule has features of death do-
main containing receptors, such as some members of the
TNFR family. Thus, TCR signals may stimulate expres-
sion of a TNFR family member which is neither fas, nor
CD30, nor 41BB, but which generates apoptotic signals
when engaged by an appropriate ligand expressed or se-
creted by APC.
It is conceivable that all programmed cell death is initi-
ated by signals transduced by death domains on specialized
surface receptors. From this perspective, surface death re-
ceptors would be responsible for death of DP thymocytes
stimulated either by TCR-CD28 costimulatory signals or
by CD28-independent TCR signals alone. However, it is
important to appreciate that the identity and specificity of
the death receptors induced by TCR-CD28 signals must
be different than those induced by TCR signals alone. This
conclusion is based on our data showing that TCR-CD28–
stimulated DP thymocytes kill themselves or each other,
but do not kill TCR-stimulated DP bystander cells (Fig. 3 c).
Rather, TCR-stimulated DP thymocytes are induced to
die upon subsequent interaction with APCs (Fig. 7 b).
Therefore, from the perspective that all cell death is medi-
ated by death domain containing receptors, the ligand for
TCR-CD28–induced death receptors must be expressed
on DP thymocytes themselves, whereas the ligand for TCR
induced death receptors is not expressed on DP thymocytes
but is expressed on APCs.
The importance of APCs in inducing clonal deletion in
the thymus has long been appreciated (8, 71–73). How-
ever, the mechanism by which APCs induce DP thymo-
cyte apoptosis has not been fully understood. Here we show
for the first time that APCs can induce death of TCR stim-
ulated DP thymocytes in two distinct ways via two distinct
sets of ligands. Our observation that TCR signals can in-
duce DP thymocyte apoptosis by two different mechanisms
is relevant to an understanding of clonal deletion of DP
thymocytes during normal in vivo development. In Fig. 9
we illustrate a model of in vivo clonal deletion that is based
on our present data. We propose that the two mechanisms
of TCR-mediated DP apoptosis identified in this report
Figure 8. Characterization of the CD28-independent mechanism of
DP thymocyte apoptosis. DP thymocytes from CD28 KO mice were
presetimulated with platebound anti-TCR antibody for 6 h, then cocul-
tured with APC from either gld mice or B6 Ly5.2 mice in the presence or
absence of the following reagents: anti-FcR antibody (2.4G2, 10 mg/ml);
the fusion protein CD30 Ig (10 mg/ml) which blocks CD30-CD30L in-
teractions; or a combination of anti–B7-1 and anti–B7-2 antibodies (10
mg/ml each) which blocks B7 ligand engagement by both CD28 and
CTLA-4. To compare the effects of various reagents on TCR-CD28–
mediated DPthymocyte apoptosis in experiments performed over time,
individual responses were normalized to their respective controls and the
normalized value is referred to as a killing index.
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represent two distinct strategies to rid the developing DP
thymocyte repertoire of autoreactive specificities during thy-
mocyte development (Fig. 9). Only DP thymocytes whose
TCRs bind MHC–peptide complexes on cells expressing
the CD28 ligands B7-1 or B7-2 will be killed as a conse-
quence of TCR and CD28 coengagement. Because B7-1
and B7-2 are not expressed in the thymic cortex but are
only expressed on APCs and medullary epithelial cells, this
form of clonal deletion would be confined to DP thy-
mocytes autoreactive to self-antigens encountered either at
the corticomedullary junction, where most APCs are lo-
cated, or on medullary epithelium. In contrast, high-affinity
interactions of TCR on DP thymocytes with self-antigens
in the cortex would induce expression of a surface mole-
cule that “tags” DP thymocytes for future disposal (i.e., a
“death tag”). Such DP thymocytes would not die in re-
sponse to TCR engagement per se, but would travel
through the cortex and enter the corticomedullary junction
where they would encounter a “screen” of APCs constitu-
tively expressing or secreting a ligand that bind the putative
death tag and induce apoptosis.
This model provides thre main insights. First, apoptosis
of DP thymocytes targeted for deletion occurs either at the
corticomedullary junction (CMJ) or in the thymic medulla,
regardless of whether DP cells encountered antigen in the
cortex. As a result, DP thymocyte deletion requires that
DP cells migrate out of the thymic cortex to the CMJ or
medulla which is considered to be a consequence of posi-
tive selection. Thus, our model predicts that DP thymo-
cytes can only be clonally deleted in vivo if they are first
positively selected. Observations that TCR-mediated apo-
ptosis is confined to the thymic medulla are consistent with
this perspective (74–75). Indeed, only DP thymocytes dying
of neglect appear to undergo apoptosis in the cortex (75).
Second, the model proposes that CD28-dependent and
CD28-independent mechanisms of TCR-mediated DP apo-
ptosis eliminate clones bearing TCR specific for distinct
sets of antigens: the CD28-dependent mechanism disposes
of TCR reactivities to APC and medullary antigens, whereas
the indirect, CD28-independent mechanism of TCR-medi-
ated DP apoptosis disposes of TCR reactivities to cortical
antigens. Recently, experimental mice were generated in
which expression of MHC class II was confined to cortical
epithelium (76). Our model predicts that these experimen-
tal mice would lack the CD28-dependent mechanism of
death because medullary cells expressing B7 (thymic APC or
medullary epithelium) would lack MHC class II expression
and fail to engage TCR on DP thymocytes. Indeed, T cells
in these animals were not tolerant to self-antigens on Class
II1 APCs. Importantly, while CD28-dependent clonal de-
letion is absent in these mice, our model predicts that the
CD28-independent mechanism of clonal deletion should
be intact, so that their CD41 T cells would be tolerant to
self-antigens expressed on class II1 cortical epithelium.
Third, the model predicts that there can be a delay be-
tween the receipt of a negative selecting TCR signal and
the death of the cell by the CD28-independent mecha-
nism. Thus, the presence of autoreactive TCR specificities
among DP thymocytes is not necessarily indicative of a fail-
ure of negative selection.
Our efforts to define the molecular basis for CD28-depen-
dent mechanisms of TCR-mediated DP apoptosis revealed
that CD28 is surprisingly unique in its capacity to cooper-
ate with TCR to directly produce apoptotic signals. Even
molecules that have been described as augmenting prolifer-
ation of mature T cells, such as CD9, CD43, CD81, CD27,
41BB, and CD30, were not able to stimulate TCR-medi-
ated death of DP thymocytes, so DP thymocyte apoptosis is
not the result of simultaneous engagement of TCR with
any costimulatory molecule. Rather, CD28 appears to gen-
erate unique second signals whose identities have not yet
been elucidated. Interestingly, TCR-CD28–induced thy-
mocyte apoptosis does not require the activity of PI 3-kinase,
one molecule known to associate with CD28.
The identity of the APC-derived signals responsible for
CD28-independent thymocyte apoptosis is not known.
While such signals may well involve molecules containing
death domains, this study has ruled out two attractive can-
didates, CD30 and 41BB (Fig. 1 b). However, proteins ex-
Figure 9. Proposed model of two distinct mechanisms of intrathymic
DP clonal deletion. Applying the present data to in vivo thymocyte de-
velopment, we propose that there are two distinct mechanisms by which
autoreactive DP thymocytes are deleted in the thymus. CD28-dependent
mechanism (right): DP thymocytes recognizing self-antigens on B71 cells
(i.e., medullary epithelial cells or APCs) are killed by signals generated by
simultaneous engagement of TCR and CD28. TCR-CD28 coengage-
ment may directly initiate an apoptotic program (i) or may upregulate a
death domain containing receptor that signals death upon interaction with
its ligand on DP thymocytes (ii). CD28-independent mechanism (left):
DP thymocyte expressing TCR’s recognizing self-antigens on cortical ep-
ithelium do not die as a consequence of TCR engagement. Instead, they
are induced to express a surface molecule (i.e., a death tag, X) that signals
them to undergo apoptosis upon subsequent interaction with APC’s
present in the CMJ. It should be noted that in this model, both mecha-
nisms of clonal deletion of autoreactive DP thymocytes are proposed to
occur in the CMJ or medulla even if they encounter self-antigen in the
cortex.
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pressing death domains continue to be identified. In fact,
three newly identified molecules containing death domains
(DR-3, DR-4, and TRAMP) are expressed in lymphopoi-
etic tissues (56–58).
Finally, it is important to draw a distinction between TCR-
mediated apoptosis of DP thymocytes and the phenome-
non of negative selection. Negative selection refers to any
process that rids a developing T cell repertoire of an auto-
specificity. Although TCR-mediated clonal deletion of DP
thymocytes is thought to be a major component of nega-
tive selection, it is clearly not the only mechanism responsi-
ble for negative selection. Indeed, we have previously shown
that thymocytes can be developmentally arrested before the
DP stage in response to TCR signals (3) and others have
shown that negative selection can occur after the DP stage
of development (77–79). In all likelihood the molecular
mechanisms that operate at these other developmental stages
(both pre- and post-DP) are distinct from those responsible
for TCR-dependent apoptosis of DP thymocytes. In sup-
port of this possibility, it is interesting to note that (a) trans-
genic bcl-2 expression does not always affect negative se-
lection (36) even though it abrogates clonal deletion of DP
thymocytes and (b) fas appears to play a role in the TCR-
mediated death of semimature T cells in the thymus (79)
but clearly does not play a role in the TCR-mediated death
of rigorously purified DP thymocytes.
In conclusion, this study identified both TCR-indepen-
dent and TCR-dependent mechanisms of DP thymocyte
apoptosis and reveals that TCR-dependent mechanisms of
DP thymocyte death occur by two mechanisms: (a) a CD28-
dependent mechanism in which TCR and CD28 costimu-
latory signals must be received simultaneously to generate
apoptotic signals and (b) a CD28-independent mechanism
in which TCR signals are indirectly responsible for apo-
ptosis by upregulating molecules which, when subsequently
engaged by APCs, will induce cell death. We propose that
these two mechanisms represent two distinct strategies used
by the thymus to dispose of autoreactive DP thymocytes
and that the strategy used depends on where the antigen is
encountered. Hence, DP thymocytes autoreactive to corti-
cal antigens will be removed from the T cell repertoire by
the indirect CD28-independent mechanism, whereas DP
thymocytes autoreactive to APC or medullary cell antigens
will be removed from the repertoire by CD28-dependent
mechanisms (Fig. 9). Thus, the present study reveals an un-
expected diversity of molecular mechanisms responsible for
TCR-specific clonal deletion.
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